Save the date for our first Synthetic Biology Industrial Translation Showcase
- Posted on 12 March
Driving the industrial base of the bioeconomy and advanced manufacturing
In recent years the combined expertise and innovation of UK biologists and engineers has catapulted the UK to the position of being amongst the international leaders in the field of synthetic biology/engineering biology. The opportunity today is to drive growth in the UK bioeconomy, potentially worth trillions of pounds globally, by extending knowledge and understanding of the many industries that can benefit from the field.
This event is set to mark a significant milestone in SynbiCITE’s history. Over the last four years SynbiCITE has played a leading role in successfully putting UK synthetic biology/engineering biology on the agenda for industry, investors and policy makers - as a technology that can make a significant economic impact and a positive difference to the world.
World-leading speakers from industry, academia, investors and government will be participating in the meeting. They will deliver fresh insights on the future of engineering biology, its relevance to the UK economy, and the impact our leading businesses are making on the future of health, agriculture, manufacturing, biofuels, water purification and pharmaceutical & medical technologies.
This is an important event. Some of the most influential thought leaders in the field will converge to address fundamental issues affecting businesses in the field today, as well as strategies for investment and growth. This information exchange is an opportunity not to miss.
This, invitation only, event will take place on Tuesday 5th June 2018, at the Royal Academy of Engineering, London 9am-5pm.
Further information will be made available soon.
Share this article:
People also read
Prokarium secures $10 million investment
Prokarium secures $10 million investment from Saudi, Swedish and Korean investors for clinical development of revolutionary thermostable vaccinesKeele...
Transformational European Commission Grant dramatically accelerates novel biomaterial company Customem
CustoMem, founded in 2015 by two Imperial College London graduates, Henrik Hagemann and Gabi Santosa, has received a substantial €1.4m grant that will...
SynbiCITE welcomes RebelBio to London
We're the world's first early stage life sciences accelerator. Twice a year we invest up to $250K in startups solving global challenges with life itse...